Turbine Expands Scientific Advisory Board to Put Virtual Disease Models in Every Scientist's Hands PressReach · Jul 10, 2025
Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FSHD (Facioscapulohumeral Muscular Dystrophy) using universal iPS cells PressReach · Jul 10, 2025
Solenic Medical Appoints Medical Device Industry Veteran Bart Bandy as Chief Executive Officer PressReach · Jul 10, 2025
MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption PressReach · Jul 10, 2025
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders PressReach · Jul 10, 2025
Pioneering alliance between The Jackson Laboratory and The New York Stem Cell Foundation ushers in new era of predictive biomedical research PressReach · Jul 10, 2025
Jungbunzlauer Showcases Bioavailable Mineral Innovations for Gummies at IFT FIRST 2025 PressReach · Jul 10, 2025
XRP Healthcare Appoints Capital Markets Executive Anna Skowron as Chief Financial Officer Ahead of Proposed TSXV Listing PressReach · Jul 9, 2025
First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418 PressReach · Jul 9, 2025
